113 results on '"Demuth T"'
Search Results
2. An Accessible Pharmacodynamic Transcriptional Biomarker for Notch Target Engagement
3. O-026 Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): phase 2 results
4. Molecular targets of glioma invasion
5. OA05.03 Tepotinib in Patients with Advanced NSCLC with MET Exon 14 (METex14) Skipping: Overall Efficacy Results from VISION Cohort A
6. 1283P Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A
7. 15-P-12-Ab-initio study of the adsorption and reactions of hydrocarbons in mordenite
8. 15-O-02 - Ab-initio simulation of dynamical processes in zeolites
9. Catalytic isomerization of 2-pentene in H-ZSM-22—A DFT investigation
10. Extraframework Aluminum Species in Zeolites: Ab Initio Molecular Dynamics Simulation of Gmelinite
11. Linear Hydrocarbons Adsorbed in the Acid Zeolite Gmelinite at 700 K ab Initio Molecular Dynamics Simulation of Hexane and Hexene
12. Ab initio molecular dynamics simulation of hydration and ion-exchange processes in low Al-zeolites
13. STEM, PED and EELS: A powerful combination for the investigation of cathode-active-materials for batteries
14. Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC) : phase 2 results
15. Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
16. 3310 LOGIC2: Phase 2, multi-center, open-label study of sequential encorafenib/binimetinib combination followed by a rational combination with targeted agents after progression, to overcome resistance in adult patients with locally-advanced or metastatic BRAF V600 melanoma
17. LBA-08 Results of a phase 1b study of the selective BRAF V600 inhibitor encorafenib in combination with cetuximab alone or cetuximab + alpelisib for treatment of patients with advanced BRAF-mutant metastatic colorectal cancer
18. 11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
19. Encorafenib (Lgx818), an Oral Braf Inhibitor, in Patients (Pts) with Braf V600E Metastatic Colorectal Cancer (Mcrc): Results of Dose Expansion in an Open-Label, Phase 1 Study
20. CLIN-PEDIATRICS CLINICAL RESEARCH
21. S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.
22. Update on a phase I pharmacologic and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors.
23. Abstract P3-12-09: Numb Expression Varies by Hormone Receptor Status among Danish Breast Cancer Patients
24. Abstract PD05-12: Combination of Notch Inhibitor MK-0752 and Endocrine Therapy for Early Stage ERα + Breast Cancer in a Presurgical Window Pilot Study
25. 651 DISCUSSION Pharmacodynamic evaluation of pCDC2 and Wee1 signature as biomarkers of target engagement for the Wee1 tyrosine kinase inhibitor MK-1775
26. ChemInform Abstract: Heteroatom-Facilitated Ortho-Directed Lithiations of 2-Arylimidazoles.
27. A phase I pharmacological and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors.
28. A phase I trial of MK-0752 in children with recurrent or refractory CNS malignancies: A Pediatric Brain Tumor Consortium study.
29. A phase I and pharmacological study of MK-1775, a Wee1 tyrosine kinase inhibitor, in both monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors
30. Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
31. Effects of zeolite pore sizes on the mechanism and selectivity of xylene disproportionation—a DFT study
32. Catalytic conversion of hydrocarbons over zeolites from first principles
33. 535P - Encorafenib (Lgx818), an Oral Braf Inhibitor, in Patients (Pts) with Braf V600E Metastatic Colorectal Cancer (Mcrc): Results of Dose Expansion in an Open-Label, Phase 1 Study
34. Structural and acidic properties of mordenite. An ab initio density-functional study
35. Spontaneous proton transfer in Na zeolites
36. ChemInform Abstract: Synthesis of 2‐(Hydroxymethyl)‐1β‐methylcarbapenem. Chemoselective Organometallic Addition to 3‐Substituted 4‐[(R)‐1‐Carboxyethyl]azetidin‐2‐one.
37. A Periodic DFT Study of Isobutene Chemisorption in Proton-Exchanged Zeolites: Dependence of Reactivity on the Zeolite Framework Structure
38. Spontaneous proton transfer between O-sites in zeolites
39. ChemInform Abstract: A REGIOSPECIFIC APPROACH TO 6-DEOXYANTHRACYCLINONES: THE STRUCTURE OF Γ-CITROMYCINONE
40. ChemInform Abstract: STEREOSPECIFIC SYNTHESIS OF (.+‐.)‐SESBANINE AND ITS C‐10 EPIMER
41. Carburetor Icing Tests in the Laboratory and in Service
42. Bilateral anonymity and prevention of abusing logged Web addresses
43. Glioma cells on the run – the migratory transcriptome of 10 human glioma cell lines
44. Bilateral anonymity and prevention of abusing logged Web addresses.
45. ChemInform Abstract: Heteroatom-Facilitated Ortho-Directed Lithiations of 2-Arylimidazoles.
46. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
47. "Depo-all-around": A novel FIB-based TEM specimen preparation technique for solid state battery composites and other loosely bound samples.
48. The Race for Hydroxamate-Based Zirconium-89 Chelators.
49. In vitro Colon Fermentation of Soluble Arabinoxylan Is Modified Through Milling and Extrusion.
50. Structural investigation of oxidized arabinoxylan oligosaccharides by negative ionization HILIC-qToF-MS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.